ArticleJPRAS open2026
Lateral perforator flap: A surgically and oncologically safe method for patients with breast cancer.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chestwall perforator flaps have been used in breast conservation after wide local excision for more than a decade. Although the technique is promising, it still needs to be standardized. For example, no published studies have numerically proven that the operated breast retains its features after operation and radiation. This study compared preoperative- and 1-year postoperative measurements to investigate whether there are any significant changes to the breast. Methods: The study examined all patients with breast cancer who were operated on with a lateral chest wall perforator flap in a primary setting between the years 2011 and 2021 at the surgical department of Kristianstad Central Hospital. Volume, ptosis, and the sternal notch-nipple distance were measured by the clinician, and standardized photos were analysed with BCCT.core software to determine the cosmetic outcome. A Likert scale of 1-10 was used to subjectively measure cosmetic outcomes. Results: 139 patients diagnosed with breast cancer or DCIS were operated on with breast-conserving surgery and a lateral perforator flap during the study period. For statistical analysis the untreated breast served as the patient's own control. No difference was found in regard to volume, but the sternal notch-nipple distance and ptosis decreased slightly but significantly by 6 and 5 mm,resepectively ( Conclusions: This study shows that lateral chest wall perforator flaps are a surgically and oncologically safe technique that conserves common features of the breast according to measurements before and 1 year after operation and radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.